Liao and colleagues (73) demonstrated that, in a mice MI model, two-week r-irisin administration increased cardiac function, alleviated ventricular dilation, and decreased infarct size and fibrosis at four weeks after MI. This evidence concerns the gene FNDC5 and myocardial infarction.